Gilead Sciences | GILD - EPS - Lucro por Ação

Preço das Ações
129.26
Mudança Diária
-0.41 -0.32%
Mensal
-4.86%
Anual
21.76%
Q2 Previsão
126.98

Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 2.03 1.9 1.81 May/07
FY2025Q4 Dec/2025 1.86 1.89 1.90 Feb/10
FY2025Q3 Sep/2025 2.47 2.16 2.02 Oct/30
FY2025Q2 Jun/2025 2.01 1.94 2.01 Aug/07
FY2025Q1 Mar/2025 1.81 1.76 3.34 Apr/24




Eps Alterar Data
AbbVie USD 2.65 0.06 2026-03
Agios Pharmaceuticals USD -1.69 0.17 2026-03
ALKERMES USD -0.4 0.69 2026-03
Alnylam Pharmaceuticals USD 1.99 0.74 2026-03
Amgen USD 5.15 0.14 2026-03
Biogen USD 3.57 1.58 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Coherus Biosciences USD -0.43 0.06 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Gilead Sciences USD 2.03 0.17 2026-03
GlaxoSmithKline GBP 0.43 0.17 2026-03
Glaxosmithkline GBP 0.62 0.41 2026-03
Incyte USD 1.81 0.01 2026-03
J&J USD 2.7 0.24 2026-03
Merck USD -1.28 3.32 2026-03
Moderna USD -3.4 1.29 2026-03
Neurocrine Biosciences USD 1.94 0.06 2026-03
Novartis USD 1.99 0.04 2026-03
Pfizer USD 0.75 0.09 2026-03
PTC Therapeutics USD -0.03 1.64 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.88 0.35 2026-03
Sarepta Therapeutics USD 3.16 6.74 2026-03
United Therapeutics USD 5.82 1.88 2026-03
Vertex Pharmaceuticals USD 4.47 0.56 2026-03